![Ben Askew](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Askew
Directeur/Membre du Conseil chez AsclepiX Therapeutics LLC
Postes actifs de Ben Askew
Sociétés | Poste | Début | Fin |
---|---|---|---|
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | - | - |
Xontogeny LLC
![]() Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/09/2019 | - |
Surf Bio, Inc.
![]() Surf Bio, Inc. Pharmaceuticals: MajorHealth Technology Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Ben Askew
Anciens postes connus de Ben Askew
Sociétés | Poste | Début | Fin |
---|---|---|---|
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 12/08/2011 | - |
Formation de Ben Askew
Gannon University | Undergraduate Degree |
University of Pittsburgh | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Third Rock Ventures LLC
![]() Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
AsclepiX Therapeutics LLC
![]() AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Commercial Services |
Xontogeny LLC
![]() Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Health Technology |
Surf Bio, Inc.
![]() Surf Bio, Inc. Pharmaceuticals: MajorHealth Technology Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation. | Health Technology |